193 related articles for article (PubMed ID: 16505098)
1. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.
Yang H; Zhao R; Lee MH
Mol Cancer Ther; 2006 Feb; 5(2):253-60. PubMed ID: 16505098
[TBL] [Abstract][Full Text] [Related]
2. Negative cell cycle regulator 14-3-3sigma stabilizes p27 Kip1 by inhibiting the activity of PKB/Akt.
Yang H; Zhang Y; Zhao R; Wen YY; Fournier K; Wu HB; Yang HY; Diaz J; Laronga C; Lee MH
Oncogene; 2006 Aug; 25(33):4585-94. PubMed ID: 16532026
[TBL] [Abstract][Full Text] [Related]
3. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability.
Su CH; Zhao R; Zhang F; Qu C; Chen B; Feng YH; Phan L; Chen J; Wang H; Wang H; Yeung SC; Lee MH
Cancer Res; 2011 Feb; 71(3):884-94. PubMed ID: 21135113
[TBL] [Abstract][Full Text] [Related]
4. Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF.
Hemmati PG; Normand G; Gillissen B; Wendt J; Dörken B; Daniel PT
Oncogene; 2008 Dec; 27(53):6707-19. PubMed ID: 18806827
[TBL] [Abstract][Full Text] [Related]
5. DNA damage-induced protein 14-3-3 sigma inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer.
Yang H; Wen YY; Zhao R; Lin YL; Fournier K; Yang HY; Qiu Y; Diaz J; Laronga C; Lee MH
Cancer Res; 2006 Mar; 66(6):3096-105. PubMed ID: 16540659
[TBL] [Abstract][Full Text] [Related]
6. 14-3-3sigma expression as a prognostic marker in undifferentiated nasopharyngeal carcinoma.
Chan SY; To KF; Leung SF; Yip WW; Mak MK; Chung GT; Lo KW
Oncol Rep; 2010 Oct; 24(4):949-55. PubMed ID: 20811675
[TBL] [Abstract][Full Text] [Related]
7. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ
Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3 sigma positively regulates p53 and suppresses tumor growth.
Yang HY; Wen YY; Chen CH; Lozano G; Lee MH
Mol Cell Biol; 2003 Oct; 23(20):7096-107. PubMed ID: 14517281
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3sigma and p21 synergize to determine DNA damage response following Chk2 inhibition.
Meng S; Arbit T; Veeriah S; Mellinghoff IK; Fang F; Vivanco I; Rohle D; Chan TA
Cell Cycle; 2009 Jul; 8(14):2238-46. PubMed ID: 19502805
[TBL] [Abstract][Full Text] [Related]
10. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
[TBL] [Abstract][Full Text] [Related]
11. Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms.
Deng M; Zhang W; Tang H; Ye Q; Liao Q; Zhou Y; Wu M; Xiong W; Zheng Y; Guo X; Qin Z; He W; Zhou M; Xiang J; Li X; Ma J; Li G
Oncogene; 2013 Sep; 32(36):4273-83. PubMed ID: 23069661
[TBL] [Abstract][Full Text] [Related]
12. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
Hu W; Xiao L; Cao C; Hua S; Wu D
Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
[TBL] [Abstract][Full Text] [Related]
13. 14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation.
Zhang Y; Karas M; Zhao H; Yakar S; LeRoith D
J Biol Chem; 2004 Aug; 279(33):34353-60. PubMed ID: 15187095
[TBL] [Abstract][Full Text] [Related]
14. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
15. H19/miR-675-5p Targeting SFN Enhances the Invasion and Metastasis of Nasalpharyngeal Cancer Cells.
Zhang T; Lei F; Jiang T; Xie L; Huang P; Li P; Huang Y; Tang X; Gong J; Lin Y; Cheng A; Huang W
Curr Mol Pharmacol; 2019; 12(4):324-333. PubMed ID: 31677258
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the p53-MDM2 pathway by 14-3-3 sigma and other proteins.
Lee MH; Lozano G
Semin Cancer Biol; 2006 Jun; 16(3):225-34. PubMed ID: 16697215
[TBL] [Abstract][Full Text] [Related]
17. Aberrant overexpression of an epithelial marker, 14-3-3sigma, in a subset of hematological malignancies.
Motokura T; Nakamura Y; Sato H
BMC Cancer; 2007 Nov; 7():217. PubMed ID: 18036248
[TBL] [Abstract][Full Text] [Related]
18. Targeted proteomic analysis of 14-3-3sigma in nasopharyngeal carcinoma.
Huang WG; Cheng AL; Chen ZC; Peng F; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Li XH; Yi B; Xiao ZQ
Int J Biochem Cell Biol; 2010 Jan; 42(1):137-47. PubMed ID: 19828132
[TBL] [Abstract][Full Text] [Related]
19. DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance.
Danilov AV; Neupane D; Nagaraja AS; Feofanova EV; Humphries LA; DiRenzo J; Korc M
PLoS One; 2011; 6(10):e26815. PubMed ID: 22053213
[TBL] [Abstract][Full Text] [Related]
20. Sensitizing hormone-refractory prostate cancer cells to drug treatment by targeting 14-3-3sigma.
Han B; Xie H; Chen Q; Zhang JT
Mol Cancer Ther; 2006 Apr; 5(4):903-12. PubMed ID: 16648560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
